| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Sep―04 |
Clinically informative microRNAs for SARS-CoV-2 infection |
Sercan Ergün, Ramamoorthy Sankaranarayanan, Nina Petrović |
| 2 |
[GO] |
2023―May―02 |
COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape |
Mrinal K Ghosh, Sunny Kumar, Kirat K Ganguly, Pratyay Ghosh, Shaheda Tabassum, Bhaskar Basu, Malini Basu |
| 3 |
[GO] |
2022―Jan―13 |
The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks |
Milad Shirvaliloo |
| 4 |
[GO] |
2021―Jul―06 |
Implication of epitranscriptomics in trained innate immunity and COVID-19 |
Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan |
| 5 |
[GO] |
2021―Apr―20 |
Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection |
Milad Shirvaliloo |
| 6 |
[GO] |
2021―Mar―09 |
An immune epigenetic insight to COVID-19 infection |
Bimal P Jit, Sahar Qazi, Rakesh Arya, Ankit Srivastava, Nimesh Gupta, Ashok Sharma |
| 7 |
[GO] |
2020―Nov―26 |
An integrative analysis identifying transcriptional features and key genes involved in COVID-19 |
Guoping Li, Junyi Wang, Xiang He, Lei Zhang, Qin Ran, Anying Xiong, Dehong Wu, Lingjuan Hu, Qi Song, Dong Zhu |
| 8 |
[GO] |
2020―Sep―02 |
Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2 |
Antonella Baldassarre, Alessandro Paolini, Stefania Paola Bruno, Cristina Felli, Alberto Eugenio Tozzi, Andrea Masotti |
| 9 |
[GO] |
2020―Jun―04 |
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
Sameer Ayaz, Francesco Crea |
